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Voltage-clampstic properties have been proposed to underlie the modulation of voltage-gated
Na+ and L-type Ca2+ channels and GABAA receptors by amphiphiles. The amphiphile Triton X-100 increases
the elasticity of lipid bilayers at micromolar concentrations, assessed from its effects on gramicidin channel A
appearance rate and lifetime in artiﬁcial lipid bilayers. In the present study, the pharmacological action of
Triton-X 100 on GABAA receptors expressed in Xenopus laevis oocytes was examined. Triton-X 100 inhibited
GABAA α1β3γ2S receptor currents in a noncompetitive, time- and voltage-dependent manner and increased
the apparent rate and extent of desensitization at 10 μM, which is 30 fold below the critical micelle
concentration. In addition, Triton X-100 induced picrotoxin-sensitive GABAA receptor currents and
suppressed allosteric modulation by ﬂunitrazepam at α1β3γ2S receptors. All effects were independent of
the presence of a γ2S subunit in the GABAA receptor complex. The present study suggests that Triton X-100
may stabilize open and desensitized states of the GABAA receptor through changes in lipid bilayer elasticity.
© 2009 Elsevier B.V. All rights reserved.1. Introduction
γ-aminobutyric acid (GABA) is the major inhibitory neurotrans-
mitter in the central nervous system. The inhibitory action is mediated
via activation of metabotropic GABAB and ionotropic GABAA receptors,
respectively. The fast inhibitory GABAergic synaptic transmission is
primarily controlled by the chloride conducting GABAA receptors [1].
These receptors belong to the Cys-loop superfamily of ligand-gated
ion channels that includes the glycine receptor, the nicotinic
acetylcholine (nACh) receptor, the 5-hydroxytryptamine (5-HT3)
receptor, and the recently identiﬁed zinc-activated ZAC receptor [2].
Pharmacological modulation of the GABAA receptors has been
studied in great detail. However, it is poorly characterized how the
lipid bilayer-embedded receptor is modulated by the physical proper-
ties of the cell membrane, lipids, and membrane-perturbing amphi-
philic compounds. An increasing number of studies show that the
lipid composition of themembrane strongly inﬂuences the function of
bilayer-embedded proteins [3–7]. The incorporation of cholesterol or
free fatty acids can signiﬁcantly affect the activity of integral
membrane proteins. Furthermore, changes in lipid characteristics,
such as head group type, fatty acyl chain length or degree of45 35 32 75 26.
ll rights reserved.unsaturation strongly modulate the activity of integral membrane
receptors. However, the molecular mechanisms underlying such
lipid–protein interactions have been difﬁcult to uncover. Accumulat-
ing evidence suggests that lipids can modulate protein function via
“nonspeciﬁc” mechanisms involving changes in the biophysical
properties of the membrane bilayer rather than direct lipid–protein
interactions [8–12].
The best documented nonspeciﬁc lipid–protein interactions are
those that result from a hydrophobic coupling between the hydro-
phobic length of the protein and the hydrocarbon thickness of the
surrounding lipid bilayer, which exists to avoid a lipid–protein
hydrophobic mismatch [13–17]. One model proposes that regulation
of protein function could result from such protein–bilayer hydro-
phobic interactions that couple protein conformational changes to
elastic deformations of the surrounding membrane bilayer [13–
15,17,18]. The elastic properties of a membrane bilayer can be
modulated by amphiphiles, and changes in elasticity can be assessed
using gramicidin A channels as force transducers [19]. Indeed, speciﬁc
amphiphiles chosen due to their ability to alter membrane elasticity
also modulate the function of voltage-gated Na+ and L-type Ca2+
channels and of GABAA receptors [9,18]. These studies show a close
correlation between amphiphile effects on voltage-gated ion channel
function and their effects on gramicidin A channel activity, strongly
suggesting that changes in bilayer elasticity underlie the channel
modulation.
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model compound that increases lipid bilayer elasticity at con-
centrations 30- to 100-fold below the critical micelle concentration
(CMC) [9,18]. Thus, it can be used to investigate the possible inﬂuence
of bilayer elasticity on a given membrane protein. Interestingly, early
studies have shown that Triton X-100 increases speciﬁc [3H]-muscimol
or [3H]-GABA binding to GABA receptors in membrane preparations
obtained from vertebrate brain [20–26]. This enhanced binding has
been suggested to be due to the liberation of endogenous inhibitors
from the membranes or synaptosomal structures [26–28]. However,
we have recently shown that Triton X-100 and other amphiphiles
known to affect the elasticity of artiﬁcial lipid bilayers modulated
agonist binding and electrophysiological properties of α1β2γ2S GABAA
receptors in a similar manner. The amphiphiles had very different
chemical structures and modulated GABAA receptor function at the
concentrations that alter lipid bilayer elasticity [29]. This study strongly
suggested that the amphiphiles modulate the function of GABAA
receptors through a bilayer-mediated mechanism analogous to that
proposed for voltage-gated ion channels [9,18].
In the present study we performed a more detailed pharmacolo-
gical investigation of the effects of Triton X-100 on the electrophy-
siological properties of GABAA receptor channels at concentrations
that increase the elastic properties of lipid bilayers without causing
membrane disruption. Recombinantα1β3γ2S orα1β3 GABAA receptors
were expressed in Xenopus laevis oocytes and receptor-mediated
currents were recorded using the two-electrode voltage-clamp
technique. To elucidate the underlying mechanism(s) of action, we
also examined the putative allosteric effect of Triton X-100 using the
benzodiazepine-site agonist ﬂunitrazepam.
2. Materials and methods
2.1. Chemicals and cDNA
The cDNAs encoding human α1, β3 and γ2S GABAA receptor
subunits engineered into a pCDM8 (α1) or a pcDNAI/Amp (β3 and
γ2S) vector (Invitrogen, San Diego, CA, USA) were gifts from Dr Paul
Whiting and are described in [30]. Flunitrazepam was synthesized at
H. Lundbeck (Denmark). Triton X-100 (protein-grade, 10% solution)
was purchased from Calbiochem (La Jolla, CA, USA) and picrotoxinwas
from Sigma-Aldrich (Denmark). Drug solutions were prepared by
diluting aqueous stock solutions of GABA (0.5 M) and Triton X-100
(10%) and dimethyl sulfoxide (DMSO) stock solutions of ﬂunitraze-
pam (10 mM) and picrotoxin (50 mM) in the extracellular solution.
The ﬁnal concentration of DMSO did not exceed 0.1% (v/v), which had
no effect on currents in GABAA receptor expressing oocytes.
2.2. Expression of GABAA receptors in X. laevis oocytes
Surgical removal of oocytes from a X. laevis frog and oocyte
preparation were performed as previously described [31]. Xenopus
oocytes were collected under anaesthesia. The protocol complies with
the European Community guidelines for the use of experimental
animals, and the experiments were approved by The Danish National
Committee for Animal Studies. Before cRNA injection, the oocytes
were kept for 24 h at 19 °C in Kulori buffer consisting of: 90 mM NaCl,
1 mM KCl, 1 mM MgCl2, 1 mM CaCl2, 5 mM HEPES (pH 7.4). Capped
cRNAs encoding human α1 and β3 and γ2S GABAA receptor subunits
were produced by in vitro transcription of linearized expression
vectors containing α1, β3 and γ2S cDNAs using mCAP mRNA Capping
kit (Stratagene, La Jolla, CA, USA). Each oocyte was injected with 50 nl
of distilled H2O containing α1, β3 and γ2S cRNAs in a ratio of 1:1:1
(approximately 6.67 ng cRNA of each subunit, i.e. 20 ng cRNA in total)
using a Nanoject microinjector (Drummond Scientiﬁc, USA). For
expression of α1β3 receptors, 50 nl cRNA solution pr. oocyte was
injected, containing 10 ng cRNA of each subunit. Oocytes were kept at19 °C in Kulori medium for 3–6 days before the experiments were
performed.
2.3. Electrophysiology
Whole-cell GABA-evoked currents were recorded from isolated
oocytes 2–7 days after RNA injection using the two-electrode voltage-
clamp technique. Intracellular recording pipettes were pulled on a PIP5
vertical micropipette puller (HEKA Elektronics, Germany) and ﬁlled
with 1 M KCl solution. The microelectrodes had open tip resistances of
0.5–1.5 MΩ. Oocytes were placed in a custom-made recording chamber
(20 μl) and continuously superfused (about 3 ml/min) with Na100
buffer, which contained 100 mM NaCl, 2 mM KCl, 1 mM CaCl2, 1 mM
MgCl2, and 10 mM HEPES (pH 7.4 adjusted with NaOH). Drugs were
applied in the bath solution using a gravity-driven drug-delivery system
(ValveBank8, AutoMate Scientiﬁc Inc., CA, USA). Cells were voltage
clamped at −60 mV for all experiments unless otherwise stated. The
currents elicited in response to the application of drugs were recorded
at room temperature (20–23 °C) using a Warner OC 725C ampliﬁer
(Warner Instruments Inc, UK) interfaced to a Pentium II-based
computer via a Digidata 1322A digitizer (Axon Instruments, Foster
City, CA, USA). Awashout period of 3–10minwas allowed between each
GABA application, depending on the duration and the GABA concen-
tration, to ensure complete recovery from desensitization. When Triton
X-100 was applied at a concentration that was 30-fold below the
critical micelle concentration (CMC, ∼300 μM), no effect was observed
on the membrane conductance, and the modulatory effects on GABAA
receptor currents were reversible. Thus, Triton X-100 did not cause
membrane damage at this concentration (0.0006% v/v, 10 μM). At a
concentration of 100 μM (∼3-fold below the CMC), which directly
activated picrotoxin-sensitive currents in GABAA-receptor expressing
oocytes, Triton X-100 has been shown not to cause any signiﬁcant
changes in passive membrane properties (membrane resistance,
membrane capacitance or membrane potential) in noninjected oocytes
[32], in agreement with our ﬁndings (data not shown).
To verify incorporation of the γ2S into the GABAA receptor
complexes, the sensitivity toward the positive allosteric modulator
ﬂunitrazepam and the allosteric inhibitor Zn2+ was established.
Studies have shown that the absence of a γ2 subunit renders α1β3
GABAA receptors insensitive to benzodiazepine-mediated modulation
and highly sensitive to Zn2+ (IC50 0.1 μM) [33]. Co-expression ofα1, β3
and γ2S cRNAs resulted in GABA-activated currents that were
potentiated by ﬂunitrazepam (1 μM) and had a low sensitivity to
inhibition by Zn2+ (10 μM), verifying the expression of α1β3γ2S
GABAA receptors (data not shown).
To determine the action of Triton X-100 on the GABA current–
voltage relationship, GABA currents were evoked by 3 μM GABA. At
this concentration, receptor desentitization was slow and a steady
state current was reached within a few minutes. Upon reaching a
steady-state current level, short hyperpolarizing or depolarizing
pulses were applied from the holding potential of−60 mV to various
test potentials between −100 mV and +60 mV, ﬁrst in the absence
and subsequently in the presence of Triton X-100. The leak (and
endogenous) currents at the different membrane potentials were
measured in the absence of GABA and subtracted from the GABA-
induced currents. All current values were normalized to the GABA-
induced steady-state current at −80 mV and plotted as a function of
the membrane potential. GABA reversal potentials were determined
by linear regression including data points near the x-axis intersection
of the current–voltage (I–V) relationships.
2.4. Data analysis
Data acquisition and analysis were performed with pCLAMP
software v8.0 (Axon Instruments, Foster City, CA, USA). Data plotting
and statistical analyses were done with Origin v6.1 (OriginLab, MA,
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Concentration–response curve ﬁtting was done with GraphPad Prism
using a nonlinear least square method to ﬁt the data to the Hill
equation I= Imax A½ nH= ECnH50 + A½ nH
 
, where I is the peak amplitude of
a current activated by a given concentration of agonist, Imax is the
maximal current produced by a saturating concentration of agonist
([A]), EC50 is the concentration of agonist eliciting a half-maximal
response and nH is the Hill coefﬁcient.
To assess the effect of Triton X-100 on the apparent extent of
desensitization for the GABA response in α1β3γ2S or α1β3 receptors,
GABA (15 and 5 μM, respectively) was applied for 5 min to allow the
desensitization process to reach a steady state. Steady-state currents
of these GABA responses were determined by extrapolation using the
Levenberg–Marquardt least squares method to ﬁt the desensitization
time course to a two- or three component exponential function of the
form I tð Þ=ΣAie −t=τið Þ + C, where I is the current at time t; A is the
relative amplitude of the component; i is the number of exponential
functions; τ is the time constant; and C is the extrapolated steady-
state current. Using the ﬁtted steady-state current values, the observed
extent of desensitization after 5 min of GABA application was
estimated to be 94.7±0.7% of the steady-state extent for α1β3γ2S
receptor responses to GABA alone and 99.4±0.1% for responses to
GABA co-applied with Triton X-100 (pre-applied for 60 s) and/or
ﬂunitrazepam. Thus, at the end of these GABA applications the current
decay was close to steady state, and therefore the ratio of ‘end current’
to peak current was used to assess the extent of desensitization.
For α1β3 receptor responses to GABA, the corresponding values
were 88.8±1.2% and 99.3±0.4% in the absence and presence of Triton
X-100, respectively. Thus, the ratio of end current to peak current
would slightly underestimate the extent of desensitization for the
control responses in these experiments. Notably, for GABA responsesFig. 1. Time-dependent and reversible effects of Triton X-100 on GABAAα1β3γ2S receptor curr
responses to 60-s applications of GABA (15 μM) in the absence or presence of 10 μMTriton X-1
with GABA or pre-applied for 60 s before co-application with GABA. (B) The current evoke
normalized with respect to peak current amplitude and superimposed for comparison of the c
of Triton X-100 (10 μM) were normalized to the peak currents induced by GABA alone and p
3 μM GABA (left panel) or 30 μM GABA (right panel) in the absence or presence of 10 μM Tr
responses to GABA plus Triton X-100 (thick traces). Note the different time scales. (E) The effe
been normalized to the control GABA response.in the presence of Triton X-100 the peak current value was likely to be
underestimated due to the strongly increased rate of desensitization,
which would lead to an underestimation of the extent of desensitiza-
tion for these responses as well.
Data points are presented in text and ﬁgures as mean±standard
error (SE). Statistical differences were determined using a one-way
analysis of variance (ANOVA) with Dunnett's and/or Bonferroni's post
hoc tests or a Student's t-test, at a signiﬁcance level of pb0.05.
3. Results
3.1. Functional properties of α1β3γ2S GABAA receptors
Application of 15 μM GABA to Xenopus oocytes injected with cRNA
encoding the α1β3γ2S GABAA receptor subunits activated fast inward
currents that desensitized rapidly (Fig. 1A). Flunitrazepam (1 μM) and
diazepam (1 μM) both enhanced the response, whereas ZnCl2 (10 μM)
had little effect (data not shown), indicating that the responses indeed
were mediated by α1β3γ2S GABAA receptors. The EC50 and Hill
coefﬁcient for the GABA concentration–response relationship were
10.1 μM (95% CI: 9.0–11.5 μM) and 1.1±0.1, respectively (Fig. 2). This
experimental systemwas used throughout the study unless otherwise
stated.
3.2. Triton X-100 suppresses peak currents and increases the apparent
rate of desensitization of α1β3γ2S GABAA receptors
In subsequent studies, the effects of Triton X-100 (10 μM) on
α1β3γ2S GABAA receptors were investigated. Fig. 1 shows that co-
application of GABA (15 μM) and Triton X-100 signiﬁcantly reduced
the peak amplitude (by 26±2%; pb0.0001; n=7) and increased theents evoked by GABA. (A) Current traces recorded from a single oocyte showing current
00 at a holding potential of−60mV. Triton X-100was either co-applied simultaneously
d by GABA alone and the response to GABA and Triton X-100 (pre-applied) have been
urrent decay time courses. (C) The peak currents evoked by 15 μMGABA in the presence
lotted as a function of the Triton X-100 pre-application time. (D) Current responses to
iton X-100. The currents evoked by GABA alone (thin traces) are superimposed on the
cts of Triton X-100 (10 μM) on peak currents induced by 3 μMor 30 μMGABA. Data have
Fig. 3. Triton X-100 suppression of steady-state currents through α1β3γ2S GABAA
receptors exhibits voltage dependence. (A) Steady-state values of currents activated by
3 μM GABA are plotted against the holding potential (Vh) in the absence (control, black
circles) or presence (open circles) of 10 μM Triton X-100. All GABA currents have been
normalized to the control current value at−80 mV (n=3–6). (B) Current responses to
3 μM GABA in the absence and presence of Triton X-100 (10 μM) in an oocyte voltage-
clamped to −60 mV. Upon reaching a steady-state current level, Vh was stepped to
potentials between−100 and+60mV. (C)Quantitative evaluation of the effect of Triton
X-100 (10 μM) is presented as percentage of control at holding potentials between−100
and+60mV. Note that currents at−20 mV have been omitted (−20 mV is close to the
reversal potential of GABAA receptor currents; thus, GABA currents were negligible).
Fig. 2. GABA concentration–response curves of α1β3γ2S receptors in the presence or
absence of Triton X-100. GABA was applied in the absence (black circles) or presence of
10 μM Triton X-100 (open circles) to Xenopus oocytes expressing GABAA receptors with
the subunit combination α1β3γ2S. Inward currents are normalized to the peak
amplitude of currents evoked by a GABA concentration inducing the maximal response
(Imax). Nonlinear regression analysis of the data sets (n=5–6) was performed as
described in the Materials and methods section.
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in agreement with previously reported data for α1β2γ2S GABAA
receptors expressed in HEK293 cells [29]. The effects of Triton X-100
were fully reversible (Fig. 1A). A more pronounced effect was
observed after pre-application for 60 s of Triton X-100 (Fig. 1, A and
C), which led to a 41±3% reduction of the peak amplitude (pb0.0001;
n=6), compared to the effects seen with co-application of GABA and
Triton X-100 without pre-treatment. As illustrated in Fig. 1C, the
relative peak amplitudes after pre-treatment with Triton X-100 for
30, 60 and 120 s did not differ signiﬁcantly, indicating that the
maximal Triton X-100 effect was achieved within the ﬁrst 30 s of pre-
treatment. A 60-s pre-treatment period was used in all subsequent
experiments. Since repeated co-application of GABA and Triton X-100
did not result in an increased inhibition of the peak response to
GABA, no indication of use dependent block by Triton X-100 was
detected (data not shown).
The effect of Triton X-100 on GABA-evoked peak currents was
strongly dependent on the GABA concentration (Fig. 1D and E). At a
GABA concentration of 3 μM (∼3 fold below EC50), Triton X-100 only
marginally affected the peak current (6±10% inhibition; n=5),
whereas the peak current to 30 μMGABA (∼3 fold above the EC50) was
reduced by 54±3% (pb0.001; n=4).
3.3. Mechanism of action of Triton X-100 at α1β3γ2S GABAA receptors
To determine whether the inhibitory effects of Triton X-100 on
GABA-elicited peak responses were competitive or noncompetitive,
GABA concentration–response curves were generated in the absence
or presence of 10 μM Triton X-100, respectively (Fig. 2). Triton X-100
resulted in a small, but signiﬁcant rightward parallel shift (nH=1.1±
0.1 and 0.9±0.1) of the GABA concentration–response curve (EC50
[and 95% CI]: 10.1 [9.0–11.5 μM] to 16.7 [13.0–21.4 μM], p=0.0003)
with a suppression of the maximum response to GABA (from 100% to
68±2%, pb0.0001). This suggests a mixed competitive/noncompe-
titive mechanism of inhibition.
To investigate whether Triton X-100 may interact with GABAA
receptors at a binding sitewithin the channel pore, we determined the
effects of the amphiphile on the current–voltage (I–V) relationship
(Fig. 3). Using a GABA concentrationwell below the EC50 value (3 μM),
the I–V relationship was determined in the absence and presenceof Triton X-100, respectively (10 μM, pre-applied for 1 min). As
illustrated in Fig. 1E, Triton X-100 had a marginal effect on the
peak amplitude of currents evoked by 3 μM GABA, but a signiﬁcant
suppression was seen with respect to the steady-state current.
The quantitative data showed that Triton X-100 suppressed the
GABA-evoked steady-state current at all holding potentials between
−100 mV and+60 mV and that the inhibitionwas signiﬁcantly more
pronounced at positive potentials (Fig. 3A and C). In the presence of
Triton X-100, the current level was 38±2% of the control level at
−40 mV vs. 20±2% of the control level at +40 mV. As illustrated in
Fig. 3A, Triton X-100 had little effect on the reversal potential of the
GABA-activated currents (−24 mV and −20 mV in the absence and
presence of Triton X-100, respectively). These values correspond
Fig. 4. Activation of picrotoxin-sensitive inward currents by 100 μM Triton X-100. A
voltage-clamp recording from a single oocyte expressing α1β3γ2S GABAA receptors is
shown (Vh=−60 mV). Inward currents were evoked by 100 μM Triton X-100 in the
absence and then presence of the GABAA receptor blocker picrotoxin (PTX, 50 μM).
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the experimental solution used [34,35], indicating that the detergent
did not affect the ionic selectivity of the channels or activate novel
non-Cl− conducting channels.
3.4. Direct effect of Triton X-100 on α1β3γ2S GABAA receptors
On oocytes expressing α1β3γ2S GABAA receptors, low concentra-
tions (≤10 μM) of Triton X-100 had only minor or no direct effects on
the membrane conductance. However, a slowly activating inward
current was observed at a higher concentration (100 μM) of Triton X-
100 (Fig. 4), amounting to 0.9±0.2% of the peak current induced by
1 mM GABA. This current was not observed in noninjected oocytes
and could be almost completely inhibited by the GABAA receptor
antagonist picrotoxin (50 μM), suggesting that Triton X-100 at higher
micromolar concentrations may mediate activation of α1β3γ2S GABAA
receptors in the absence of GABA (or change the GABAA receptor
conformation into a conductive state).Fig. 5. Triton X-100 suppresses positive modulation of α1β3γ2S GABAA receptors by ﬂunitra
showing current responses to 5-min applications of GABA (15 μM), GABA in the presence of T
and GABA in the presence of Triton X-100 plus ﬂunitrazepam. (B) The currents shown in (A
comparison of the current decay time courses. (C) and (D) Effects of Triton X-100 (TX100)
amplitude and the relative magnitude of the ‘end current’ of responses to 15 μMGABA. The re
to control (GABA alone) and end currents were measured at the end of the 5-min GABA app
columns ‘Triton X-100’ and ‘TX100 and FNZ’ in (C) were not signiﬁcantly different.3.5. Effect of Triton X-100 on allosteric modulation of α1β3γ2S
GABAA receptors
To investigate the effects of Triton X-100 on the allosteric pro-
perties of the GABAA receptor, the interaction between Triton X-100
and the benzodiazepine-site agonist ﬂunitrazepam was examined. In
agreement with previously described data [36], ﬂunitrazepam (1 μM)
enhanced the peak amplitude of currents induced by 15 μM GABA
(162±11% of control, p=0.002, n=6) (Fig. 5C) and concomitantly
increased the rate of desensitization. The potentiation of GABA
currents by ﬂunitrazepam was abolished by co-administration of
Triton X-100 (the resulting current was 81±4% of the response to
GABA (p=0.003)). Although ﬂunitrazepam slightly increased the
response to GABA in the presence of Triton X-100 (from 70±4% to
81±4% of control), this effect was not signiﬁcant (p=0.106). The
current decay in the presence of GABA appeared to be faster when
Triton X-100 and ﬂunitrazepam were co-applied than when either of
the two modulators were applied alone (Fig. 5B).
The extent of desensitizationwas assessed as the magnitude of the
‘end current’ relative to the peak current of responses to 5-min GABA
applications (see Materials and methods). Triton X-100 and ﬂuni-
trazepam (1 μM) both signiﬁcantly reduced the ratio of end current to
peak current of GABA responses, whether applied alone or in
combination, indicating that both compounds increased the extent
of desensitization (Fig. 5D, pb0.0001). In control responses, the ratio
of end current to peak current was 0.17±0.01, whereas in the
presence of Triton X-100, ﬂunitrazepam, or Triton X-100 and
ﬂunitrazepam it was reduced to 0.08±0.01, 0.07±0.01 and 0.06±
0.01, respectively (n=6–10). A one-way ANOVA analysis revealed no
difference in end current to peak current ratio for GABA responses in
the presence of Triton X-100, ﬂunitrazepam, or the two in combina-
tion. This suggests that ﬂunitrazepam did not further increase the
extent of desensitization of responses to GABA in the presence ofzepam. (A) Current recordings from a single oocyte at a holding potential of −60 mV
riton X-100 (10 μM, pre-applied for 60 s), GABA in the presence of ﬂunitrazepam (1 μM),
) have been normalized with respect to peak current amplitude and superimposed for
and ﬂunitrazepam (FNZ), applied either alone or in combination, on the peak current
sults were obtained in experiments as that in (A). Peak current values were normalized
lications. Asterisks denote signiﬁcant difference from the control value (n=6–10). The
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desensitization by the compounds was also found when this
parameter was estimated from the ratio of extrapolated steady-state
current to peak current (data not shown, see Materials and methods).
3.6. The effect of Triton X-100 on α1β3 GABAA receptors
Since Triton X-100 suppressed the positive allosteric effect of
ﬂunitrazepam, which is dependent on the presence of the γ subunit
[37], this might indicate that Triton X-100 uncoupled the contribution
of the γ2 subunit to the overall properties of the GABAA receptor. We
therefore further examined whether the modulatory effects of Triton
X-100 are dependent on the presence of a γ subunit in the GABAA
receptor. In oocytes expressing α1β3 GABAA receptors, Triton X-100
caused a small, but signiﬁcant, suppression (9±2%; p=0.005; n=5)
of the peak currents evoked by 5 μMGABA and increased the apparent
rate of desensitization (Fig. 6A–C). The concentration of GABA was
chosen so that the relative levels of activation ofα1β3 receptors (5 μM,
EC50 3 μM (data not shown)) and α1β3γ2S receptors (15 μM, EC50
10 μM)were comparable. The inhibitory effect of Triton X-100 on peak
currents was signiﬁcantly stronger on receptors containing the γ2S
subunit (Fig. 1C (41%) and Fig. 6D (9%)).
Furthermore, Triton X-100 reduced the ratio of end current to peak
current from 0.27±0.01 to 0.13±0.01 (pb0.0001; n=5) (Fig. 6D),
indicating an increase in the extent of desensitization at these
receptors in the presence of Triton X-100. Thus, the presence of a
γ-subunit is not essential for the ability of Triton X-100 to modulate
the activity of the GABAA receptor.Fig. 6. The effects of Triton X-100 on GABAA receptor peak currents and apparent
desensitization are not dependent on the γ subunit. (A) GABA currents in a single
oocyte expressingα1β3 GABAA receptors at a holding potential of−60mV. The currents
were evoked by 5-min applications of GABA (5 μM) in the absence or presence of Triton
X-100 (10 μM), whichwas pre-applied for 60 s. (B) The currents shown in (A) have been
normalized with respect to peak amplitude and superimposed. (C) and (D) Effects of
Triton X-100 (TX100) on GABA peak current amplitude and ratio of GABA ‘end’ current
to peak current. Data are from ﬁve experiments as that in (A). Peak currents are
normalized to control. ‘End currents’ were measured at the end of the GABA
applications. The asterisks denote signiﬁcant difference from control (pb0.01 (⁎⁎) or
pb0.001 (⁎⁎⁎)).4. Discussion
This study investigated the effects of the amphiphile Triton X-100
on currents mediated by recombinant α1β3γ2S and α1β3 GABAA
receptors. The ﬁnding that Triton X-100 affects the apparent rate and
extent of desensitization is in agreement with our previous data
showing the ability of amphiphiles to modulate the function of GABAA
α1β2γ2S receptors heterologously expressed in mammalian cells [29].
However, it should be noted that the suppression of peak currents in
the present study is likely to have been overestimated due to the fast
current kinetics in the presence of Triton X-100. Fast kinetic events are
poorly resolved in two-electrode voltage-clamp recordings in the
Xenopus oocyte expression system; thus, a more accurate determina-
tion of fast kinetic parameters should be performed in a different
experimental system. The effects of Triton X-100 could be explained
by several distinct mechanisms of action. First, this amphiphilic
compound may interact with the GABAA receptors in a speciﬁc
pharmacological manner through binding to distinct sites on the
receptors accessible from either the aqueous extracellular phase or
through the lipid membrane hydrophobic interior. Second, Triton
X-100 partitions into lipid bilayers and has been shown to change the
elastic properties of artiﬁcial lipid bilayers and biological membranes
[9,18]. It is possible that altered bilayer elastic properties could change
the conformational restraint exerted by the surrounding membrane
on the receptor protein, thereby resulting in a shift of the protein
conformational equilibrium toward desensitized receptor states. We
recently provided evidence that such a nonspeciﬁc mechanism may
underlie the modulation by Triton X-100 and other amphiphiles of
GABAA receptor currents in a mammalian expression system [29]. In
agreement with this hypothesis, studies have provided evidence that
Triton X-100 promotes inactivation of L-type Ca2+ and voltage-gated
Na+ channels at low micromolar concentrations through changes in
lipid bilayer elastic properties [9,18]. Third, Triton X-100 might
“destabilize” the GABAA receptor complex through a direct, but
nonspeciﬁc, interaction with hydrophobic cavities in the protein or a
disruption of important hydrophobic interactions in the transmem-
brane region of the protein.
Several issues emerging from this study may shed light on the
mechanism(s) underlying the effects of Triton X-100 and need to be
discussed in greater detail. The ﬁrst aspect is the stronger inhibitory
effect of Triton X-100 on GABA-evoked steady-state currents than on
peak currents. This characteristic cannot be fully explained as a result
of slow associationwith receptor binding sites accessible in the resting
state as it was also observed when Triton X-100 had been pre-applied
for several minutes before application of GABA. This may indicate that
receptor activation facilitates interaction of Triton X-100 with an
inhibitory site, e.g., a site in the channel lumen. However, repeated
GABA applications in the presence of Triton X-100 did not lead to
accumulated inhibition, as would be expected for an open-channel
blocker unless the association rate was very fast. Furthermore, the fact
that pre-incubation in Triton X-100 increases blockade of peak
currents indicates that the amphiphile also interacts with closed
receptor states. Additionally, a rebound current was not observed
upon simultaneous removal of GABA and Triton X-100. Rebound
currents are a characteristic of GABAA receptor antagonists proposed
to act as open channel blockers such as penicillin, furosemide and
isoﬂurane [38–40]. Thus, although it cannot be excluded that Triton
X-100 interacts with a site in the channel pore, such a mechanism is
unlikely to explain the observed inhibitory effect.
As evident from the I–V relationships (Fig. 3), the suppression of
steady-state currents in the presence of Triton X-100 was more
pronounced at positive membrane potentials, suggesting that Triton
X-100 interacts with a site on the receptor within the membrane
electric ﬁeld. This could be in the channel pore. However, consistent
with previous reports, GABA responses in the absence of Triton X-100
exhibited signiﬁcant rectiﬁcation, which has been suggested to be due
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receptors [41]. The observed voltage dependence of Triton X-100 may
therefore be a consequence of the rectiﬁcation rather than a direct
block of the channel pore, i.e. the actions of Triton X-100 might be
facilitated by receptor activation, which is higher at positive than
negative potentials.
It is interesting that Triton X-100 is able to almost abolish the
enhancement by ﬂunitrazepam of GABA-evoked currents mediated by
α1β3γ2S GABAA receptors. This could suggest a speciﬁc pharmacolo-
gical interaction of Triton X-100 with the benzodiazepine site.
However, the observed effects were independent on the presence of
a γ subunit in the receptor complex, ruling out the benzodiazepine
site as the molecular target for Triton X-100. At high concentrations
Triton X-100 acted as a GABAA receptor agonist. A possible explanation
is the existence of a second speciﬁc interaction site on the receptor
complex of lower afﬁnity than the putative inhibitory/modulatory
site, as suggested for neurosteroids and barbiturates ([42,43]).
However, this idea seems unlikely as it implies that the stimulatory
effect of binding to such a low-afﬁnity site can be detected in the
presence of a strong, possibly maximal, stimulation of the inhibitory
site. If the inhibitory actions of the amphiphile on GABA-evoked
currents were mediated by a pore-blocking mechanism, Triton X-100
would be expected to exert a robust inhibitory effect at a 30-fold
higher concentration. In addition, a rebound current was not observed
upon removal of Triton X-100.
Although contradictory at ﬁrst, both the inhibitory and stimula-
tory actions of Triton X-100 could be accounted for by a single, simple
mechanism of action by which Triton X-100 changes bilayer elastic
properties and thereby causes a shift in the conformational
equilibrium of the receptor toward the open and desensitized states.
The currents activated by the amphiphile at high micromolar
concentrations had very small amplitudes relative to the maximal
GABA response, which indicates that Triton X-100 may have a weak
stabilizing effect on the agonist-unbound open state of the receptor.
This putative open-state stabilization was not apparent from
recordings that showed the action of Triton X-100 on GABA-evoked
currents. However, it is plausible that such an effect would be
obscured by the substantial increase in the apparent rate of current
desensitization observed in the presence of Triton X-100; particularly
in two-electrode voltage clamp recordings on oocytes in which peak
currents are poorly resolved. This mechanism would also explain the
well-established ability of Triton X-100 to increase high-afﬁnity
agonist binding to native GABAA receptors [20,23–25,27,28]. Such
stabilization of open and desensitized states could be due to a direct
interactionwith the receptor complexes but it is also possible that the
effect is mediated indirectly by changes in membrane elasticity, as we
recently proposed [29]. It should be noted that the evidence that
suggests that Triton X-100 increases bilayer elasticity at low
micromolar concentrations is provided by measurement of its effect
on gramicidin channel activity [19,44]. The possibility that amphi-
philic compounds such as Triton X-100 interact speciﬁcally with
gramicidin channels, e.g., at the subunit–subunit interface, cannot be
excluded; however, speciﬁc interactions between amphiphiles and
these simple peptide ion channels have not been identiﬁed. Thus, a
strong stabilization of the desensitized receptor state(s) concomi-
tantly with a stabilization of the open state by Triton X-100 may
explain the results.
A few studies provide evidence that the modulatory effects of
Triton X-100 observed in this study are not restricted to GABAA
receptors but may extend to other Cys-loop receptors. A recent study
shows that Triton X-100 and Tween 80, but not cholic acid, Tocrisol or
DMSO noncompetitively inhibits agonist-induced nACh receptor
currents without altering the potency of the agonist acetylcholine,
suggesting that the receptor inhibition is not a general property of
detergents [32]. Triton X-100 furthermore stabilizes reconstituted
nACh receptors in an apparently desensitized state [45], supportingthe hypothesis that GABAA receptors are stabilized in a similar state by
Triton X-100.
It cannot be excluded that the underlying cause of the observed
effects of Triton X-100 on GABAA receptor currents is a “destabiliza-
tion” of the GABAA receptor protein complex through a nonspeciﬁc,
but direct, interaction of the amphiphile with hydrophobic cavities or
interference with structurally important interactions in the protein.
This could affect the ability of the receptors to undergo the
conformational changes that underlie channel opening and receptor
desensitization. However, since several structurally distinct mem-
brane proteins, such as voltage-dependent Na+ and L-type Ca2+
channels and nACh receptors are affected similarly by Triton-X, this
seems rather unlikely.
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